Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view
Age is the main risk factor for a number of human diseases, including neurodegenerative
disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral …
disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral …
Determinants of dopaminergic neuron loss in Parkinson's disease
DJ Surmeier - The FEBS journal, 2018 - Wiley Online Library
The cardinal motor symptoms of Parkinson's disease (PD) are caused by the death of
dopaminergic neurons in the substantia nigra pars compacta (SN c). Alpha‐synuclein …
dopaminergic neurons in the substantia nigra pars compacta (SN c). Alpha‐synuclein …
The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells
The self-assembly of α-synuclein (αS) into intraneuronal inclusion bodies is a key
characteristic of Parkinson's disease. To define the nature of the species giving rise to …
characteristic of Parkinson's disease. To define the nature of the species giving rise to …
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
Oligomeric species populated during the aggregation process of α-synuclein have been
linked to neuronal impairment in Parkinson's disease and related neurodegenerative …
linked to neuronal impairment in Parkinson's disease and related neurodegenerative …
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease
Protein aggregation causes α-synuclein to switch from its physiological role to a pathological
toxic gain of function. Under physiological conditions, monomeric α-synuclein improves ATP …
toxic gain of function. Under physiological conditions, monomeric α-synuclein improves ATP …
Interaction of mitochondrial calcium and ROS in neurodegeneration
AY Baev, AY Vinokurov, IN Novikova, VV Dremin… - Cells, 2022 - mdpi.com
Neurodegenerative disorders are currently incurable devastating diseases which are
characterized by the slow and progressive loss of neurons in specific brain regions …
characterized by the slow and progressive loss of neurons in specific brain regions …
Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation
PR Angelova, ML Choi, AV Berezhnov… - Cell Death & …, 2020 - nature.com
Protein aggregation and abnormal lipid homeostasis are both implicated in
neurodegeneration through unknown mechanisms. Here we demonstrate that aggregate …
neurodegeneration through unknown mechanisms. Here we demonstrate that aggregate …
Alpha-synuclein oligomers: a new hope
N Bengoa-Vergniory, RF Roberts, R Wade-Martins… - Acta …, 2017 - Springer
Alpha-synuclein is a protein implicated in Parkinson's disease and thought to be one of the
main pathological drivers in the disease, although it remains unclear how this protein elicits …
main pathological drivers in the disease, although it remains unclear how this protein elicits …
Alpha-synuclein aggregation pathway in Parkinson's disease: current status and novel therapeutic approaches
M Vidović, MG Rikalovic - Cells, 2022 - mdpi.com
Following Alzheimer's, Parkinson's disease (PD) is the second-most common
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …
Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
Protein misfolding is a general hallmark of protein deposition diseases, such as Alzheimer's
disease or Parkinson's disease, in which different types of aggregated species (oligomers …
disease or Parkinson's disease, in which different types of aggregated species (oligomers …